Pitney Bowes is up. The selling did not wait.


Pitney Bowes PITNEY BOWES INC /DE/ is not being sold in a vacuum. The stock has already re-rated hard, and the market has been willing to pay up for a name that can show some operating leverage in a postage, shipping, and presort business that still lives with rate changes, volume swings, and a lot of investor skepticism. That is the backdrop. The filing is the hook.
Todd A. Everett, the EVP and President of SendTech, sold 25,000 shares on August 5 at a weighted average price of $18.068, with trades ranging from $18.00 to $18.17. The filing, submitted August 6, values the transaction at approximately EUR 391,714, euro-normalised at ingest, and about $451,700 in the filing currency terms reported by the market data. On its own, that is a mid-sized sale. In context, it lands inside a much larger run of insider selling at a stock that has already moved a long way.
The clean comparison is not some random industrial name with a low multiple. It is UPS, and to a lesser extent FedEx, because those are the operators that set the tone for parcel economics, pricing discipline, and how much volume growth the market is willing to underwrite. Pitney Bowes is smaller and more specialized, but it still lives in the same broad conversation about shipping demand, rate pressure, and whether the revenue line can keep up with the cost base.
That matters because the sector backdrop is not broken. Pitney Bowes’ own shipping index says parcel shipping volume grew 3.3% in 2025 to 23.1 billion shipments, with revenue growth outpacing volume as carriers pushed profitability over pure throughput. The same backdrop also carries a warning label. New U.S. Postal Service rates took effect in July 2026, and the macro picture still includes a Federal Reserve that held its target range at 3.50% to 3.75% in late July, with core PCE inflation near 3.4% and GDP growth projected at 1.5% to 2.0% for the year. That is not a collapse. It is a slower, more selective market.
UPS and FedEx can absorb that environment with scale. Pitney Bowes has to translate it through SendTech and Presort, where the company has less room for error and less patience from the market if execution slips. The stock’s 70% plus year-to-date gain says the market has already moved from disbelief to partial acceptance. The insider sales say management is happy to take some chips off the table at these levels.
Todd Everett’s sale is the cleanest filing to start with because it is specific, recent, and tied to an operating role that actually touches the business. He is the EVP and President of SendTech, not a passive director. His August 5 sale of 25,000 shares at $18.068 was not the largest transaction in the cluster, but it was enough to matter because it came after a string of larger disposals tied to CEO Kurt James Wolf.
InsiderTrades data gives the filing a display score of 48. That is not a verdict, and it is not a forecast. It reflects the mix of factors in front of us, including that the seller is a chief executive level insider in the broader cluster, that the trades are clustered, and that the filing value is meaningful relative to the company’s market value. The transaction represented about 0.02% of Pitney Bowes’ market cap, which is not a balance sheet event, but it is large enough to register as a deliberate sale rather than noise.
The more interesting point is timing. The stock closed near $18.30 on August 5, after trading between $8.95 and $19.07 over the prior 52 weeks. That puts Everett’s sale close to the top of the range, not in the middle of it. You do not need to invent motive to read that. A senior insider sold after a sharp rerating, and he sold while the stock was already sitting near the high end of the year’s range.
The larger story is the cluster around President and CEO Kurt James Wolf. Entities linked to him reported open-market sales of more than 1.05 million shares between July 30 and August 3 at weighted average prices between $17.53 and $18.962. Earlier in July, there were sales of over 522,000 shares under a 10b5-1 plan. That is a lot of paper moving out the door in a short window.
This is where the comparison with UPS and FedEx helps. At the larger carriers, insider selling can be routine, especially after compensation vesting or prearranged plans. At a smaller, more idiosyncratic name like Pitney Bowes, a cluster of sales from the top of the house after a strong move is harder to treat as background static. It does not tell you the business is deteriorating. It does tell you the people with the most direct exposure to the company’s operating cadence have chosen to reduce exposure while the market is still rewarding the stock.
The cluster data from InsiderTrades is plain enough. There are 12 recent declarations, two distinct insiders, and the recent list is dominated by sales from Wolf, with Everett joining in on August 6. That is the kind of pattern that matters more than any single line item. One sale can be housekeeping. A run of them, across roles, after a sharp rally, is a different read.

Pitney Bowes did not rally on nothing. Q2 2026 revenue came in at $451 million, down 2% year over year, while adjusted EPS rose to $0.43 and the company raised full-year guidance for adjusted EBIT, EPS, and free cash flow. That is enough to explain why the stock stopped looking like a broken story and started looking like a turnaround with some proof points.
The problem is that the proof points are still mixed. SendTech posted EBIT gains, while Presort declined. That split matters because it says the company is not moving in one clean line. It is improving in one pocket and still leaking in another. For a stock that has already run hard, the market usually wants more than a better quarter. It wants evidence that the better quarter is the start of a cleaner sequence.
Pitney Bowes’ own valuation has also changed with the price. BofA raised its target to $18.50 around the August earnings window, and the consensus rating remains Hold. That is a useful tell. Analysts have acknowledged the improvement, but they have not stamped the name with a full-throated rerating case. The stock is now trading in the zone where the market has to decide whether the earnings improvement is enough to justify the move already made.
The cohort bucket here is chief-executive buys at mid-cap names, and the historical numbers are not dramatic. The 90-day win rate is 49.8%, with an average return of 2.1%. That is a modest edge, not a magic trick. It says that, in this bucket, the next 90 days have historically been close to a coin flip with a slight positive drift. It does not say this trade will work.
That matters because the current case is a sale, not a buy. The cohort stat is still useful, though, because it reminds you not to overread the filing as a standalone prediction engine. The stock has already moved, the business has already improved enough to lift guidance, and the insiders have already sold a meaningful amount into that move. The historical bucket data tells you the signal lives in the pattern, not in a promise.
InsiderTrades’ broader fundamental screen is also not screaming distress. Pitney Bowes carries a fundamental score of 60, with a value score of 69 and a quality score of 51. Those are not the numbers of a business in obvious trouble. They are the numbers of a company that has enough going on to keep the market interested, but not enough clarity to make the story simple.
There is a temptation to file this away as compensation management and move on. That would be lazy. The timing, the cluster, and the price all line up too neatly for that. Everett sold after the stock had already climbed into the upper end of its 52-week band, and Wolf-linked entities had already sold more than 1.05 million shares in a matter of days, after earlier July sales under a 10b5-1 plan.
The comparison with UPS and FedEx again helps keep the scale honest. Those companies trade on freight and parcel cycles that are large enough to absorb a lot of insider activity without changing the story. Pitney Bowes is smaller, more concentrated, and more sensitive to whether the market believes the turnaround is real. When the CEO and a senior operating executive both sell into a strong move, the market is entitled to ask whether the stock has run ahead of the next leg of fundamentals.
InsiderTrades data puts the filing in a mid-cap bucket with a 90-day historical average return of 2.1%, but the more immediate question is simpler. Can Pitney Bowes keep converting the Q2 improvement into something that survives the next rate change, the next shipping cycle, and the next quarter of scrutiny? That is the question the stock has to answer now, not the filing.
The first thing to watch is whether the company can keep the guidance raise from looking like a one-quarter event. Q2 already gave the market a reason to believe, but the revenue line still fell 2% year over year. If the next update shows more of the same split, with SendTech doing the heavy lifting and Presort lagging, the market may start to treat the rerating as complete.
The second thing is whether insider selling continues. One filing from Everett would be manageable. A cluster that already includes more than 1.05 million shares from Wolf-linked entities, plus earlier July sales under a 10b5-1 plan, is the kind of pattern that deserves follow-through. If the selling stops, the market can decide it was mostly a post-rally cleanup. If it continues, the message gets clearer.
The third thing is the stock itself. At around $18.30 on August 5, with a 52-week high of $19.07, Pitney Bowes is not priced like a neglected value trap anymore. It is priced like a name that has to keep earning its way forward. UPS and FedEx will keep giving you the sector read. Pitney Bowes has to give you the company-specific one, and the insiders just told you they were willing to sell before that next proof point arrives.
Dig deeper: Everett Todd A.'s filing track record.
This is not investment advice.
Twist Bioscience has rallied 265% this year, but a six-insider selling cluster and Dennis Cho's August 5 sale complicate...
NIKE COO Alagirisamy Venkatesh sold 890 shares on August 5. The filing lands beside a wider August cluster and a weak co...
Circle’s CEO filed multiple August 7 sales after Q2, while USDC growth, rate sensitivity and peer moves frame the read.
Everpure rose to $87.26 as John Colgrove sold EUR 6.1m. We read the cluster against AI storage demand, peers, and our co...
CareDx rallied 154% year to date, then director Michael Goldberg sold EUR 1.83m after Q2 revenue rose 52% and guidance w...
Amundi saw two August 6 sales and EUR 550,854 in recent disposals. Read the cluster against Europe asset management, Bla...